R. Don Elsey, CFO at Emergent BioSolutions Inc. (EBS), sold 7,634 shares at $19.65 ($150K) on 2009-03-11, disclosed to the SEC on 2009-03-12.
Scheduled sale ($150k) by CFO under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $19.50 | 100 | $2K | 1.3% |
| 2 | $19.51 | 100 | $2K | 1.3% |
| 3 | $19.54 | 100 | $2K | 1.3% |
| 4 | $19.57 | 300 | $6K | 3.9% |
| 5 | $19.57 | 100 | $2K | 1.3% |
| 6 | $19.59 | 1,500 |
| $29K |
| 19.6% |
| 7 | $19.60 | 200 | $4K | 2.6% |
| 8 | $19.61 | 300 | $6K | 3.9% |
| 9 | $19.62 | 100 | $2K | 1.3% |
| 10 | $19.63 | 100 | $2K | 1.3% |
| 11 | $19.64 | 200 | $4K | 2.6% |
| 12 | $19.65 | 600 | $12K | 7.8% |
| 13 | $19.66 | 300 | $6K | 3.9% |
| 14 | $19.68 | 200 | $4K | 2.6% |
| 15 | $19.69 | 200 | $4K | 2.6% |
| 16 | $19.70 | 500 | $10K | 6.6% |
| 17 | $19.71 | 200 | $4K | 2.6% |
| 18 | $19.72 | 100 | $2K | 1.3% |
| 19 | $19.73 | 600 | $12K | 7.9% |
| 20 | $19.74 | 100 | $2K | 1.3% |
| 21 | $19.76 | 100 | $2K | 1.3% |
| 22 | $19.78 | 100 | $2K | 1.3% |
| 23 | $19.79 | 100 | $2K | 1.3% |
| 24 | $19.80 | 300 | $6K | 4.0% |
| 25 | $19.85 | 200 | $4K | 2.6% |
| 26 | $19.86 | 134 | $3K | 1.8% |
| 27 | $19.87 | 200 | $4K | 2.6% |
| 28 | $19.88 | 300 | $6K | 4.0% |
| 29 | $19.89 | 100 | $2K | 1.3% |
| 30 | $19.89 | 200 | $4K | 2.6% |
| Total | $19.68 avg | 7,634 | $150K | 100% |
| Filing → |
| EBS | SELL | 2009-03-12 | $16K | — | Filing → |
| EBS | SELL | 2008-12-16 | $221K | — | Filing → |
| EBS | SELL | 2008-12-01 | $307K | — | Filing → |